Key result
Residence in the Non-Latin Caribbean was associated with higher cardiovascular disease mortality compared to North America (196.7 vs. 122.6 deaths per 100,000) despite lower rates of some traditional risk factors.
Why the study?
While global cardiovascular disease outcomes have improved, CVD-related premature mortality remains elevated in the Caribbean, particularly from stroke and hypertensive heart disease.
Cross-Sectional
Absolute Event Rate: 196.7% vs 122.6%
The Non-Latin Caribbean faces a disproportionately high burden of cardiovascular mortality compared to North America, driven by systemic healthcare gaps and poor risk factor control rather than behavioral risk factors alone.
Supports targeting healthcare gaps in Non-Latin Caribbean; leaves open drivers of regional CVD mortality beyond behaviors.
Cardiovascular disease (CVD) remains a leading cause of premature mortality in the Caribbean, with particularly high rates from stroke and hypertensive heart disease. While global outcomes have improved, CVD-related mortality in the Caribbean remains elevated. This study examined sex-specific CVD mortality, risk factors, and health policy indicators across non-Latin Caribbean nations, using data from the 2019 PAHO Enlace Portal and comparing results to North America (United States and Canada). Despite North Americans exhibiting more overall risky CVD behaviors, CVD mortality was higher in the Non-Latin Caribbean compared to North America (196.7 vs. 122.6 deaths per 100,000). Total-to-HDL cholesterol ratios were significantly higher in the Caribbean, both in men (4.01 vs. 3.63; p < 0.0001) and women (3.82 vs. 3.01; p < 0.0001), indicating reduced cardioprotective effects of HDL. Hypertensive heart disease mortality was significantly higher in Caribbean women compared to North American women (p < .01), with a similar but non-significant trend in men. Caribbean men also had significantly higher rates of undiagnosed hypertension compared to North American men (47.6% vs. 20.8%; p < .001). NCD policy implementation across the Caribbean was inconsistent, with major gaps in CVD drug therapy access, alcohol advertising restrictions, NCD planning, and surveillance systems. These findings underscore the urgent need for regional investment in prevention, policy enforcement, and culturally relevant strategies to reduce CVD disparities and improve health outcomes in the Caribbean.
No takes yet. Share an insight, caveat, or question.
Cesar Barrabi (2025) conducted a cross-sectional in Cardiovascular disease. Non-Latin Caribbean residence vs. North American residence (United States and Canada) was evaluated on Cardiovascular disease mortality (deaths per 100,000). Residence in the Non-Latin Caribbean was associated with higher cardiovascular disease mortality compared to North America (196.7 vs. 122.6 deaths per 100,000) despite lower rates of some traditional risk factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: